CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,013 | +26.5% | 67,067 | +45.5% | 1.31% | +92.1% |
| Q2 2023 | $619,530 | -18.9% | 46,096 | 0.0% | 0.68% | -27.3% |
| Q1 2023 | $764,272 | -7.9% | 46,096 | +3.4% | 0.94% | +15.7% |
| Q4 2022 | $829,541 | -8.5% | 44,599 | -24.8% | 0.81% | -10.2% |
| Q3 2022 | $907,000 | +14.4% | 59,301 | -47.6% | 0.90% | +23.2% |
| Q2 2022 | $793,000 | -3.6% | 113,077 | +13.8% | 0.73% | +22.6% |
| Q1 2022 | $823,000 | +36.5% | 99,322 | -51.1% | 0.60% | +234.1% |
| Q3 2020 | $603,000 | -35.7% | 203,133 | 0.0% | 0.18% | -42.8% |
| Q2 2020 | $938,000 | +19.9% | 203,133 | 0.0% | 0.31% | -4.6% |
| Q1 2020 | $782,000 | +15.9% | 203,133 | +12.9% | 0.33% | +37.8% |
| Q4 2019 | $675,000 | -28.8% | 179,868 | 0.0% | 0.24% | -34.1% |
| Q3 2019 | $948,000 | – | 179,868 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |